Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: Long-term observation in CML Study IV

M. B. Miranda, M. Lauseker, M. P. Kraus, U. Proetel, B. Hanfstein, A. Fabarius, G. M. Baerlocher, D. Heim, D. K. Hossfeld, H. J. Kolb, S. W. Krause, C. Nerl, T. H. Brümmendorf, W. Verbeek, A. A. Fauser, O. Prümmer, K. Neben, U. Hess, R. Mahlberg, C. PlögerM. Flasshove, B. Rendenbach, W. K. Hofmann, M. C. Müller, M. Pfirrmann, A. Hochhaus, J. Hasford, R. Hehlmann, S. Saußele

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: Long-term observation in CML Study IV'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science